Ipsen announced the appointment of Stewart Campbell as Executive Vice President and President of North America, effective immediately. Based in Cambridge, he will lead the business in the US and Canada, continuing to drive Ipsen?s positive impact for patients. He will report directly to David Loew, CEO, Ipsen and serve on the Executive Leadership Team (ELT). Stewart joined Ipsen as Senior Vice President and Franchise Head of Oncology earlier in 2021 from Roche/Genentech where he spent more than 14 years and was responsible for the lifecycle management of some of Roche?s oncology blockbusters, including both commercial and clinical development globally.